Biopharmaceutical: Biologics, Drug Development-Manufacturing

This course contains the use of artificial intelligence.Biopharmaceutical: Biologics, Drug Development-Manufacturing.The biopharmaceutical industry is transforming modern medicine faster than almost any other sector in healthcare. From monoclonal antibodies and antibody-drug conjugates to gene therapy, CAR-T therapy, and mRNA vaccines, biologics are reshaping how diseases are treated across oncology, immunology, rare diseases, and personalized medicine.But for many learners, the industry feels extremely complex.How are biologic drugs different from traditional medicines?What exactly are APIs, monoclonal antibodies, biosimilars, or ADCs?How do drugs move from laboratory discovery to clinical trials and finally commercial manufacturing?Why are biopharma companies investing billions into biologics, cell therapy, and next-generation manufacturing platforms?And how do regulations, GMP requirements, patents, CROs, CDMOs, and clinical trials all fit together?This course is designed to answer those questions in a clear, structured, and industry-focused way.Whether you are a healthcare professional, IT professional, business analyst, investor, manufacturing professional, student, engineer, or someone simply curious about modern biotechnology, this course will help you build a strong foundational understanding of the global biopharmaceutical industry.Unlike highly academic biotechnology courses that focus only on molecular biology, this course explains both the science and the industry ecosystem behind modern medicines.You will learn not only what these therapies are, but also how they are developed, manufactured, regulated, scaled, commercialized, and delivered to patients.Throughout the course, we simplify complex concepts using real-world examples, industry analogies, market trends, and practical explanations.You will begin by understanding the structure of the global pharmaceutical and biopharmaceutical in